Did You Know?

Editor’s Picks

Latest News

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026

Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity

Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue...

error: Content is protected !!